Search Results 171-180 of 3462 for Solid

  1. Mayo Clinic researchers load CAR-T cells with oncolytic virus to treat solid cancer tumors

    ... solid cancer tumors. The combination approach, published in Science ... The therapeutic strategy addresses two major challenges that make solid tumors difficult ...

  2. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration - Mayo Clinic

    The purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), ...

  3. JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation - Mayo Clinic

    ... solid tumors with KRAS G12C mutation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  4. A Study of RLY-4008 in Patients with Intrahepatic Cholangiocarcinoma and Other Advanced Solid Tumors - Mayo Clinic

    A Study of RLY-4008 in Patients with Intrahepatic Cholangiocarcinoma and Other Advanced Solid Tumors · Overview · Participation eligibility · Participating Mayo ...

  5. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors · Share · Facebook ...

  6. A Study Of PARG Inhibitor ETX-19477 In Patients With Advanced Solid Malignancies (ERADIC8) - Mayo Clinic

    ... solid cancer, excluding primary central nervous system (CNS) tumors. Any solid tumor malignancy, excluding primary CNS tumors, with progression on or after ...

  7. A Phase 1/2 Trial Of TER-2013 In Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations - Mayo Clinic

    A Phase 1/2 Trial Of TER-2013 In Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · Overview · Participation eligibility · Participating Mayo ...

  8. Solid 2011 Performance Sets Mayo Clinic on Path to Redefine Future of Health Care

    Mayo Clinic today reported a solid performance in 2011 and shared plans for growth in services and programs to meet the needs of tomorrow's patients in new ...

  9. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

    ... Solid Tumors. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

  10. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma ( ...